Conduit Pharmaceuticals I... (CDT)
0.91
0.04 (4.83%)
At close: Apr 15, 2025, 3:59 PM
0.88
-2.66%
After-hours: Apr 15, 2025, 05:53 PM EDT
4.83% (1D)
| Bid | 0.88 |
| Market Cap | 8.64M |
| Revenue (ttm) | 2.04B |
| Net Income (ttm) | -17.82M |
| EPS (ttm) | -20.53 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.9 |
| Volume | 3,236,486 |
| Avg. Volume (20D) | 5,590,391 |
| Open | 0.82 |
| Previous Close | 0.87 |
| Day's Range | 0.70 - 0.94 |
| 52-Week Range | 0.51 - 350.00 |
| Beta | 2.35 |
About CDT
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2022
Employees 6
Stock Exchange NASDAQ
Ticker Symbol CDT
Website https://www.conduitpharma.com
2 months ago
+83.87%
Conduit Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
2 months ago
-20%
Conduit Pharmaceuticals shares are trading lower after the company board approved a 1-for-100 reverse stock split.
8 months ago · 247wallst.com
4 Stocks Moving Sharply Before the Market OpensPremarket trading is some of my favorite trading to watch.
